$4.18+0.14 (+3.59%)
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
Hyperion DeFi, Inc. in the Healthcare sector is trading at $4.18. The stock is currently near its 52-week low of $1.02, remaining 25.0% below its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why HYPD maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a licen...
Hyperion DeFi Inc (HYPD) reports an impressive 87% revenue growth and strategic advancements, despite facing significant treasury losses in Q4 2025.
As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Claim 30% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana
Public companies are not just assessing crypto potential; they are buying in. Since the approval of spot ETFs in 2024 and throughout 2025, multiple firms in the US have been actively purchasing and adding top cryptos to their balance sheets. Strategy, formerly MicroStrategy, is well known for its Bitcoin holding ...
KB Home downgraded, Costco upgraded: Wall Street's top analyst calls
KB Home downgrade, Costco upgraded: Wall Street's top analyst calls